Molecular Data Inc. American Depositary Shares
MKD was delisted on the 6th of September, 2022.
10 hedge funds and large institutions have $986K invested in Molecular Data Inc. American Depositary Shares in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
11% more funds holding
Funds holding: 9 → 10 (+1)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
58% less capital invested
Capital invested by funds: $2.32M → $986K (-$1.34M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$341K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$199K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$94.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$19.9K |
| 5 |
Squarepoint
New York
|
+$4.46K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAA
TB Alternative Assets
Grand Cayman,
Cayman Islands
|
-$834K |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$523K |
| 3 |
Jane Street
New York
|
-$6K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$4K |
| 5 |
Millennium Management
New York
|
-$1.52K |
MKD Hedge Fund Activity: Q4 2021 in Review
10 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Molecular Data Inc. American Depositary Shares (MKD) for Q4 2021, worth a combined $986K — down 58% from $2.32M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new MKD positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $341K. The largest seller was TB Alternative Assets, cutting an estimated $834K.
- 10 institutional investors held Molecular Data Inc. American Depositary Shares (MKD) as of Q4 2021, up from 9 in Q3 2021.
- Funds reported $986K of Molecular Data Inc. American Depositary Shares stock for Q4 2021, down 58% quarter-over-quarter.
- 4 funds opened new Molecular Data Inc. American Depositary Shares positions in Q4 2021 and 3 closed out, a net change of +1 holder.
- The largest Molecular Data Inc. American Depositary Shares buyer in Q4 2021 was Renaissance Technologies, an estimated $341K added.
- The largest Molecular Data Inc. American Depositary Shares seller in Q4 2021 was TB Alternative Assets, an estimated $834K sold.
Based on aggregated 13F filings for Q4 2021.